Neophyr (Nitric Oxide)

Nitric Oxide, the active ingredient in Neophyr, is an unknown drug class presented as an inhalation gas for inhalation use. It promotes vasodilation of pulmonary vessels and is employed in the management of pulmonary hypertension and related respiratory conditions. It is indicated for use under medical supervision in specialized care settings.

GNH USA supplies Neophyr as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, transplant centres, oncology centres, pharmacies and clinics worldwide. The company adheres to stringent quality standards and provides regulatory support for global distribution.

Neophyr is used to target pulmonary vascular tone and related respiratory disorders.

- Persistent Pulmonary Hypertension of the Newborn (PPHN): improves oxygenation by reducing pulmonary arterial pressure. - Pulmonary Hypertension in adults: lowers pulmonary artery pressure and enhances exercise capacity. - Acute Respiratory Distress Syndrome (ARDS) adjunct: provides selective pulmonary vasodilation to improve ventilation‑perfusion matching.

Inhalation of Nitric Oxide may be associated with several adverse reactions.

Common Side Effects: - Headache: mild to moderate headache due to cerebral vasodilation. - Dizziness: transient light‑headedness during therapy. - Nausea: occasional gastrointestinal upset. - Flushing: warm sensation and skin reddening.

Serious or Rare Side Effects: - Severe methemoglobinemia: symptomatic elevation requiring treatment. - Rebound pulmonary hypertension: rapid rise in pressure after abrupt discontinuation.

When using Neophyr, several precautions should be observed to ensure patient safety.

- Pregnancy: safety not established; use only if potential benefit justifies risk. - Breastfeeding: unknown excretion; consider discontinuation or monitor infant. - Concomitant vasodilators: may potentiate hypotensive effects; monitor blood pressure. - Methemoglobin monitoring: assess levels during prolonged therapy. - Discontinuation: taper or wean to avoid rebound pulmonary hypertension. - Store at ambient temperature: keep cylinder in original packaging, protect from heat and direct sunlight.

Nitric Oxide can interact with certain medications, altering its efficacy or safety profile.

Major Interactions (Avoid): - Phosphodiesterase‑5 inhibitors (e.g., sildenafil): combined use may cause profound hypotension. - Methylene blue: can exacerbate methemoglobinemia when used together.

Moderate Interactions (Monitor Closely): - Inhaled anesthetics (e.g., sevoflurane): additive vasodilatory effect may require blood pressure monitoring. - Antihypertensive agents (e.g., ACE inhibitors): may enhance blood pressure lowering. - Anticoagulants (e.g., warfarin): increased risk of bleeding due to platelet inhibition.